Volato Group, Inc. (NYSE American: SOAR) ("Volato" or the "Company") today announced that it has suspended further borrowings/drawdowns under its convertible note facility (the "Facility"). The ...

Revolution Medicines (RVMD) priced a public offering of 10.56M shares at $142 each, raising about $1.5B, along with $500M of convertible senior notes due 2033. Both offerings were upsized from earlier ...

Borr Drilling Limited (NYSE and Euronext Growth Oslo: BORR) ("Borr Drilling" or the "Company") today announced that it intends to offer, subject to market and other conditions, $250 million aggregate ...

Revolution Medicines intends to use the net proceeds from the common stock offering and the note offering for general corporate purposes, including research and development expenses, expenses relating ...

Search Minerals Inc. (TSXV: SMY) (OTC Pink: SHCMF) ("Search Minerals" or the "Company") is pleased to announce that the Company has issued an unsecured convertible note (the "Unsecured Convertible ...

Scorpio Tankers (STNG) announced pricing of a private offering of $325M of 1.75% convertible senior notes due in 2031. This amount is an increase from the initially planned $300M. The company also ...

VANCOUVER, BC AND BREDA, NETHERLANDS / ACCESS Newswire / November 17, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQX:OGOFF)(FSE:OGF0) (“Organto” or the “Company”), is pleased to announce that it has ...

Calgary, Alberta / October 15, 2025 –TheNewswire -Credissential Inc. (“Credissential” or the “Company”) (CSE: WHIP), a vertically integrated AI software development companyis pleased to announce a non ...

Repurchasing approximately $300 million principal amount of existing convertible senior notes and removing approximately 5.2 million underlying shares as well as approximately $51.4 million of ...

"We are extremely pleased with the outstanding response to the Convertible Note Offering from high quality institutional investors in the United States, which is a tremendous endorsement of Caledonia ...

Shares of Zenas BioPharma continued to slide after the company said it would raise $200 million through a convertible senior note sale and sell 5 million shares at $20 a share in a public offering.